SSY GROUP (02005) obtained the drug production registration approval from the National Medical Products Administration for the fat-soluble vitamin injection () (10ml).

SSY GROUP (02005) announces that the group has obtained the drug production registration certificate for the liposoluble vitamin injection () (10ml) from the China National Medical Products Administration. This drug belongs to the third category of chemical drugs and is considered to have passed the consistency evaluation. SSY GROUP's liposoluble vitamin injection () is the first domestic enterprise to receive approval for this product. Liposoluble vitamin injection () is an essential component of parenteral nutrition and is mainly used to meet the physiological needs of adults and children aged 11 and above for liposoluble vitamins A, D2, E, and K1 on a daily basis.